ADVANCING IMMUNOTHERAPY in ONCOLOGY, created in 2008 (United States), from 496 sister brands and 17477 competing brands. The ADVANCING IMMUNOTHERAPY in ONCOLOGY brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. The sector of ADVANCING IMMUNOTHERAPY in ONCOLOGY is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(ADVANCING IMMUNOTHERAPY in ONCOLOGY)
over 5 years*
USD 59.90